Stock Events

Stock Events

Easton Pharmaceuticals 

$0.000020
2
+$0.00+0%Tuesday 20:00

Statistics

Day High
0.000001
Day Low
0.000001
52W High
0.00002
52W Low
0.00001
Volume
1,000
Avg. Volume
0
Mkt Cap
26,898.66
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

Sep 30Expected
Q1 2017
Q3 2017
Q1 2018
Q4 2018
Q4 2020
Q1 2021
Q2 2021
-0
-0
-0
0
Expected EPS
0
Actual EPS
-0.0001

Financials

-Profit Margin
Unprofitable
2004
2016
2017
2018
2019
2020
0Revenue
-189,000Net Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap158.45B
Pfizer Inc. is a major player in the pharmaceutical industry, developing medications that may compete directly with Easton Pharmaceuticals' products in various therapeutic areas.
Johnson & Johnson
JNJ
Mkt Cap617.01B
Johnson & Johnson manufactures a wide range of healthcare products, potentially competing across several of Easton Pharmaceuticals' product lines.
Merck
MRK
Mkt Cap356.01B
Merck & Co., Inc. is involved in the development and marketing of drugs and vaccines, including those that could compete with Easton Pharmaceuticals' offerings.
Abbvie
ABBV
Mkt Cap464.43B
AbbVie Inc. operates in similar therapeutic areas as Easton Pharmaceuticals, making it a direct competitor in the pharmaceutical sector.
Lilly(Eli) &
LLY
Mkt Cap1.02T
Eli Lilly and Company is a global pharmaceutical company that develops drugs that may compete with Easton Pharmaceuticals' products.
GSK
GSK
Mkt Cap94.23B
GlaxoSmithKline plc engages in the creation and marketing of pharmaceutical products, potentially overlapping with Easton Pharmaceuticals' market.
Novartis
NVS
Mkt Cap268B
Novartis AG is known for its extensive research and development in pharmaceuticals, competing in the same space as Easton Pharmaceuticals.
Bristol-Myers Squibb
BMY
Mkt Cap124.91B
Bristol-Myers Squibb Company offers a broad range of pharmaceutical products that could compete with those of Easton Pharmaceuticals.
Sanofi
SNY
Mkt Cap95.65B
Sanofi operates globally in the pharmaceutical sector, producing medicines that could directly compete with Easton Pharmaceuticals' products.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap46.1B
Teva Pharmaceutical Industries Limited manufactures generic and specialty medicines, which could compete with Easton Pharmaceuticals' specialty product lines.

About

Currently, Parallel Industries Inc. does not conduct substantial business operations. Historically, the company was involved in developing and commercializing various topically applied medications to treat cancer, alongside other therapeutic solutions for a range of medical conditions. Its strategic emphasis has typically covered the entire pharmaceutical process: from development and licensing to manufacturing and marketing of both prescription and over-the-counter products. Established in 1997, the firm is headquartered in Toronto, Canada, and was formerly known as Easton Pharmaceuticals Inc. before rebranding as Parallel Industries Inc. in December 2020.
Show More
CEO
Evan Karras
Employees
6
Country
United States
ISIN
US2777741057

Listings

OTC Link
US
EAPH

0 Comments

Share your thoughts

FAQs

What is Easton Pharmaceuticals stock price today?▼
The current price of EAPH is $0.00 USD — it has increased by +0% in the past 24 hours. Watch Easton Pharmaceuticals stock price performance more closely on the chart.
What is Easton Pharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Easton Pharmaceuticals stocks are traded under the ticker EAPH.
Is Easton Pharmaceuticals stock price growing?▼
EAPH stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Easton Pharmaceuticals has showed a +100% increase.
What is Easton Pharmaceuticals market cap?▼
Today Easton Pharmaceuticals has the market capitalization of 26,898.66
What were Easton Pharmaceuticals earnings last quarter?▼
EAPH earnings for the last quarter are -0 USD per share, whereas the estimation was 0 USD resulting in a -∞% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Easton Pharmaceuticals revenue for the last year?▼
Easton Pharmaceuticals revenue for the last year amounts to 0 USD.
What is Easton Pharmaceuticals net income for the last year?▼
EAPH net income for the last year is -189,000 USD.
How many employees does Easton Pharmaceuticals have?▼
As of November 1, 2026, the company has 6 employees.
In which sector is Easton Pharmaceuticals located?▼
Easton Pharmaceuticals operates in the Health & Wellness sector.
When did Easton Pharmaceuticals complete a stock split?▼
Easton Pharmaceuticals has not had any recent stock splits.
Where is Easton Pharmaceuticals headquartered?▼
Easton Pharmaceuticals is headquartered in Toronto, United States.